Heba M. Ismail

1.8k total citations
46 papers, 430 citations indexed

About

Heba M. Ismail is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Heba M. Ismail has authored 46 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Genetics and 20 papers in Surgery. Recurrent topics in Heba M. Ismail's work include Diabetes Management and Research (30 papers), Diabetes and associated disorders (27 papers) and Pancreatic function and diabetes (20 papers). Heba M. Ismail is often cited by papers focused on Diabetes Management and Research (30 papers), Diabetes and associated disorders (27 papers) and Pancreatic function and diabetes (20 papers). Heba M. Ismail collaborates with scholars based in United States, Egypt and Italy. Heba M. Ismail's co-authors include Jerry P. Palmer, Jay M. Sosenko, Carmella Evans‐Molina, Susan Geyer, Linda A. DiMeglio, Barbara Brooks‐Worrell, Amit Goel, Emily K. Sims, Andrea K. Steck and Jay S. Skyler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Heba M. Ismail

41 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba M. Ismail United States 10 284 277 259 44 38 46 430
Georgia Kassi Greece 11 248 0.9× 130 0.5× 165 0.6× 46 1.0× 42 1.1× 27 436
J. Petersen Germany 11 222 0.8× 217 0.8× 269 1.0× 34 0.8× 40 1.1× 32 555
Mustafa Tosur United States 11 200 0.7× 201 0.7× 159 0.6× 49 1.1× 23 0.6× 47 339
Yotsapon Thewjitcharoen Thailand 13 318 1.1× 102 0.4× 109 0.4× 81 1.8× 42 1.1× 63 484
Linda Thurby-Hay United States 5 230 0.8× 100 0.4× 52 0.2× 59 1.3× 35 0.9× 6 370
Katrin Nagl Austria 10 217 0.8× 178 0.6× 158 0.6× 78 1.8× 43 1.1× 16 369
Sa. Muntoni Italy 8 116 0.4× 100 0.4× 80 0.3× 47 1.1× 44 1.2× 12 255
Fatma Mnif Tunisia 12 246 0.9× 66 0.2× 69 0.3× 151 3.4× 29 0.8× 44 425
Eva Horová Czechia 7 407 1.4× 221 0.8× 222 0.9× 48 1.1× 25 0.7× 17 475
V. Sulmont France 12 539 1.9× 370 1.3× 391 1.5× 143 3.3× 21 0.6× 19 718

Countries citing papers authored by Heba M. Ismail

Since Specialization
Citations

This map shows the geographic impact of Heba M. Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba M. Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba M. Ismail more than expected).

Fields of papers citing papers by Heba M. Ismail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba M. Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba M. Ismail. The network helps show where Heba M. Ismail may publish in the future.

Co-authorship network of co-authors of Heba M. Ismail

This figure shows the co-authorship network connecting the top 25 collaborators of Heba M. Ismail. A scholar is included among the top collaborators of Heba M. Ismail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba M. Ismail. Heba M. Ismail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sims, Emily K., David Cuthbertson, Lauric Ferrat, et al.. (2025). IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 68(5). 993–1004. 2 indexed citations
2.
3.
Sosenko, Jay M., David Cuthbertson, Laura M. Jacobsen, et al.. (2025). A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technology & Therapeutics. 27(3). 179–186.
4.
Ismail, Heba M., Dimuthu Perera, Rabindra K. Mandal, et al.. (2024). Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 110(2). 364–373. 1 indexed citations
5.
Galderisi, Alfonso, Emily K. Sims, Carmella Evans‐Molina, et al.. (2024). Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab. Diabetologia. 68(3). 646–661. 2 indexed citations
6.
Sims, Emily K., David Cuthbertson, Laura M. Jacobsen, et al.. (2024). Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals. The Journal of Clinical Endocrinology & Metabolism. 109(8). 2116–2123. 4 indexed citations
7.
Ismail, Heba M., Souptik Barua, Johnny Wang, et al.. (2023). Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index. Diabetes Obesity and Metabolism. 25(11). 3420–3423. 1 indexed citations
8.
Sosenko, Jay M., David Cuthbertson, Emily K. Sims, et al.. (2023). Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes Care. 46(5). 1098–1105. 9 indexed citations
9.
Rehman, Aqeeb Ur, Huzaifa Ahmad Cheema, Talha Ahmad, et al.. (2023). Efficacy and safety of topical ruxolitinib cream for the treatment of vitiligo: A systematic review and meta‐analysis of randomized controlled trials. Journal of Cosmetic Dermatology. 23(1). 350–353. 3 indexed citations
10.
Ismail, Heba M., Maria Spall, Carmella Evans‐Molina, & Linda A. DiMeglio. (2023). Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial. Pilot and Feasibility Studies. 9(1). 150–150. 9 indexed citations
11.
Ismail, Heba M. & Carmella Evans‐Molina. (2022). Does the Gut Microbiome Play a Role in Obesity in Type 1 Diabetes? Unanswered Questions and Review of the Literature. Frontiers in Cellular and Infection Microbiology. 12. 892291–892291. 8 indexed citations
12.
Sims, Emily K., David Cuthbertson, Jamie L. Felton, et al.. (2022). Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening. Diabetes Care. 45(12). 2982–2990. 5 indexed citations
13.
Ismail, Heba M., Linda A. DiMeglio, Janey Adams, et al.. (2022). COVID-19 Pandemic Effects on Caregivers of Youth With Type 1 Diabetes: Stress and Self-Efficacy. Diabetes Spectrum. 35(4). 461–468. 7 indexed citations
14.
Ode, Katie Larson, Alberto Battezzati, Amanda Brennan, et al.. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents. Pediatric Diabetes. 23(8). 1212–1228. 33 indexed citations
15.
Fuller, Candace C., Vinod E. Nambudiri, Lesley H. Curtis, et al.. (2021). Medical chart validation of inpatient diagnosis codes for transfusion‐related acute lung injury 2013‐2015. Transfusion. 61(3). 754–766. 5 indexed citations
16.
17.
Evans‐Molina, Carmella, Emily K. Sims, Linda A. DiMeglio, et al.. (2018). β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis. JCI Insight. 3(15). 80 indexed citations
18.
Sosenko, Jay M., Susan Geyer, Jay S. Skyler, et al.. (2017). The influence of body mass index and age on C‐peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial‐type 1. Pediatric Diabetes. 19(3). 403–409. 22 indexed citations
19.
Ismail, Heba M. & Marielisa Rincon. (2014). X-Linked Adrenal Hypoplasia Congenita: A Case Report and Ethical Dilemma. Endocrine Practice. 20(7). e126–e129. 2 indexed citations
20.
Girgis, Marian, et al.. (2013). Assessment of respiratory involvement in children with mucoplysaccharidosis using pulmonary function tests. SHILAP Revista de lepidopterología. 15(1). 79–85. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgia Kassi Breakdown of academic impact, for papers by J. Petersen Breakdown of academic impact, for papers by Mustafa Tosur Breakdown of academic impact, for papers by Yotsapon Thewjitcharoen Breakdown of academic impact, for papers by Linda Thurby-Hay Breakdown of academic impact, for papers by Katrin Nagl Breakdown of academic impact, for papers by Sa. Muntoni Breakdown of academic impact, for papers by Fatma Mnif Breakdown of academic impact, for papers by Eva Horová Breakdown of academic impact, for papers by V. Sulmont
Rankless by CCL
2026